In a previous study, increased survivin/BIRC5 expression was reported in megakaryocytes from MPN patients (ET, PV, and PMF) compared to healthy donors, which was independent of the presence of JAK2V617F and CALR indel mutations.23 The gene discussed is BIRC5; the disease is myeloproliferative disorder.